Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Multifunctional bio-active medicine for preventing and curing AIDS

A bioactive agent, multifunctional technology, applied in antiviral agents, medical preparations containing active ingredients, unknown raw materials, etc., can solve the problems of weak vaccine efficacy, hindering further research and strengthening curative effect, weak antibody effect, etc. Rapid and durable immune response, broad social maneuverability, and immune-enhancing effects

Inactive Publication Date: 2002-08-14
潘文光
View PDF0 Cites 26 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

(2) Drug resistance: almost all drugs show drug resistance, and it is easy to cause HIV mutation. The rotation and combined application of several drugs only delays the emergence of drug resistance
However, the problems existing in the treatment of traditional Chinese medicine are: the lack of support of modern medical theory, and the excessive conservativeness formed by being too traditional hinders the in-depth research and strengthens the curative effect. When searching all ancient books for AIDS discussion, it was classified as "plague" and "consumption of deficiency" in traditional Chinese medicine. Deficiency of Qi and blood
But according to the current situation, it will also face some difficulties: (1), according to the current reports, the price is too expensive and does not have the significance of universal prevention
(2) Antibodies stimulated by HIV have very weak effects
(3) Even if the problem of vaccine inefficiency is solved, the repair of the patient's immune deficiency has not been solved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Embodiment 1, applicable to asymptomatic HIV carriers

[0028] AI: 1. Glycyrrhiza polysaccharide 0.5mg.

[0029] 2. Patrinia chrysalis seeds 10g. The amount is extracted as oleanolic acid and hedera saponin, and the two are mixed for later use.

[0030] 3. Bezoar bile salt 100mg. Should contain 60% sodium cholate and 40% sodium deoxycholate. Both come from bezoar.

[0031] 4. Ginkgo biloba total extract 6mg.

[0032] 5. A total of 5.1 g of SMI and SEI are the extracts of Saccharomyces chinensis, each about 50%.

[0033] 6. Gynostemma powder 0.5g

[0034] 7. VB 1 0.5mg

[0035] 8. Panax notoginseng powder 5g

[0036] 9. Antelope horn 1g powder (200 mesh)

[0037] 10. Deer antler 0.5g powder (200 mesh)

[0038] Mix the above 10 items evenly and set aside.

[0039] AII: 4g ginseng, 15g Houttuynia cordata, 10g pearl ginseng, 3g American ginseng, 10g trichosanthin, 15g codonopsis, 1.4g catechu. Add more than 250ml of wate...

Embodiment 2

[0050] Embodiment 2 is applicable to AIDS-related syndromes.

[0051] BI: 1. Catechin 150 μg.

[0052] 2. Trichosanthin protein 5g, a simple protein extracted from trichosanthes without sugar and phosphate groups,

[0053] Molecular weight 24000, isoelectric point 9.4.

[0054] 3. 6.3 μg of glycosides and aglycones extracted from arctium seeds.

[0055] 4. Licorice extract 1.5 μg.

[0056] 5. Oleanolic acid and ivy contained in 12g of Patrinia seeds

[0057] 6. Bezoar bile salt 100mg. (see embodiment one for definition)

[0058] 7. Tuimoside A 15μg

[0059] 8. VB 1 0.5mg

[0060] 9. Panax notoginseng powder 7g

[0061] 10. Ginkgo biloba total extract 8mg

[0062] 11. A total of 5.1g of SMI and SEI, both of which are extracts of Fructus Sinensis, about 50% each.

[0063] 12. Gynostemma powder 0.75g

[0064] 13. Antelope horn 2g powder (200 mesh)

[0065] 14. velvet antler 1.2g powder (200 mesh)

[0066] ...

Embodiment 3

[0078] Embodiment three, applicable to typical AIDS

[0079] CI: 1. Catechin 180 μg.

[0080] 2. Trichosanthin protein (simple protein extracted from 15g trichosanthes without sugar and phosphate groups, molecular weight 24000, isoelectric point 9.4).

[0081] 3. Glycosides and aglycones extracted from arctium seeds 13 μg.

[0082] 4. Licorice polysaccharide 0.5mg.

[0083] 5. Licorice extract 2.5mg.

[0084] 6. Oleanolic acid and ivy contained in Patrinia chrysalis seeds 15g.

[0085] 7. Tuibeimoside A 20 μg.

[0086] 8. Tripterfordin 0.3mg (tripterfordin).

[0087] 9. A total of 5.1g of SMI and SEI.

[0088] 10. Ginkgo biloba total extract 8mg.

[0089] 11. Antelope horn 2.5g powder (200 mesh).

[0090] 12. 2g powdered antler (200 mesh).

[0091] 13. VB 1 2 mg.

[0092] 14. Panax notoginseng powder 9g.

[0093] 15. Gynostemma powder 1g.

[0094] Mix the above and set aside.

[0095] CII: Houttuyni...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A multifunctional bio-activator for preventing and treating AIDS is prepared from 11 Chinese-medicinal materials including patrinia herb seed, notoginseng, Antelope's horn, pilose antler, etc; general extract of gingko leaf, SOD, CAT, GSHPx, etc. Its advantages include high suppression action to HIV, and no by-effect.

Description

1. Technical field [0001] The invention relates to a pharmaceutical preparation, in particular to a multifunctional bioactive agent specially used for the prevention and treatment of AIDS. 2. Background technology [0002] Since the first case of AIDS was reported in the United States in 1981, the disease has occurred in more than 150 countries. According to the statistics of the World Health Organization, in 1998, there were 5.8 million new infections and 2.5 million deaths worldwide. That year, 33.4 million people were infected. [0003] AIDS is caused by human immunodeficiency virus (HIV), and is a chronic and highly fatal systemic infectious disease characterized by severe impairment of cellular immune function. The disease is transmitted through sexual contact, vertical transmission from mother to child and bodily fluid transmission, clinically manifested as a series of serious opportunistic infections and malignant tumors. At present, there is no specific therapeuti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P31/18
Inventor 潘文光
Owner 潘文光
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com